Mechanism of Action of Benzonatate
Benzonatate acts peripherally by anesthetizing stretch receptors in the respiratory passages, lungs, and pleura, thereby dampening their activity and reducing the cough reflex at its source. 1
Primary Mechanism: Peripheral Anesthesia of Pulmonary Afferents
Benzonatate functions as a peripherally-acting antitussive that suppresses the afferent limb of the cough reflex 2. The drug works by:
- Anesthetizing stretch receptors located throughout the respiratory tract (respiratory passages, lungs, and pleura) 1
- Dampening sensory receptor activity to reduce cough reflex transmission at the point of origin 1
- Producing no inhibitory effect on the respiratory center at recommended dosages, distinguishing it from centrally-acting opioid antitussives 1
Molecular Mechanism: Voltage-Gated Sodium Channel Blockade
The molecular basis for benzonatate's anesthetic effect involves local anesthetic-like inhibition of voltage-gated sodium channels, particularly Nav1.7 channels that are highly expressed in vagal sensory neurons 3. This mechanism explains how benzonatate produces its peripheral anesthetic effects:
- Causes both tonic and phasic sodium channel inhibition 3
- Demonstrates greater effects on channel inactivation than activation 3
- Shows inactivated-state-specific effects with much greater potency at depolarized potentials 3
- Produces detectable effects at concentrations as low as 0.3 μM, which are achievable in humans 3
Chemical Structure and Classification
Benzonatate is chemically related to para-amino-benzoic acid class anesthetic agents (e.g., procaine, tetracaine) 1. It is a mixture of polyethoxy esters of 4-(butylamino) benzoic acid with varying degrees of hydrophobicity, with the 9-ethoxy component being the most potent sodium channel inhibitor 3.
Clinical Pharmacology
- Onset of action: 15-20 minutes 1
- Duration of effect: 3-8 hours 1
- Site of action: Exclusively peripheral with no central nervous system penetration for cough suppression 2, 1
Important Caveat
While benzonatate demonstrates local anesthetic properties on peripheral nerves in experimental settings 4, this produces significant myotoxicity even at low concentrations 4, which is not relevant to its approved antitussive use but explains why it should only be used as directed orally and never injected.